There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list
If you've ever gotten a vaccine, this company was likely part of how that drug reached you, says Josh Brown.
TL;DR
- West Pharmaceutical Services (WST) produces packaging for injectable drugs, including vials, syringes, and auto-injectors.
- The company supplies components for a wide range of pharmaceutical products, benefiting from demand for biologics, vaccines, and GLP-1 drugs.
- Following a period of inventory correction and declining performance, WST has seen a significant fundamental turnaround, with strong sales and EPS growth in Q2.
- High-value components, particularly those for GLP-1 drugs, now represent a larger portion of WST's revenue and are driving margin expansion.
- Technical indicators suggest WST is in an uptrend, with key price levels indicating potential for further upside if resistance is broken.